Structure Therapeutics Statistics Share Statistics Structure Therapeutics has 57.57M
shares outstanding. The number of shares has increased by 4.31%
in one year.
Shares Outstanding 57.57M Shares Change (YoY) 4.31% Shares Change (QoQ) 0.44% Owned by Institutions (%) 9.76% Shares Floating 54.72M Failed to Deliver (FTD) Shares 47 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 7.86M, so 13.65% of the outstanding
shares have been sold short.
Short Interest 7.86M Short % of Shares Out 13.65% Short % of Float 19.71% Short Ratio (days to cover) 11.38
Valuation Ratios The PE ratio is -11.65 and the forward
PE ratio is -10.88.
Structure Therapeutics's PEG ratio is
2.61.
PE Ratio -11.65 Forward PE -10.88 PS Ratio 0 Forward PS n/a PB Ratio 1.65 P/FCF Ratio -12.11 PEG Ratio 2.61
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Structure Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 24.74,
with a Debt / Equity ratio of 0.
Current Ratio 24.74 Quick Ratio 24.74 Debt / Equity 0 Debt / EBITDA -0.02 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-751.69K Employee Count 163 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 310K Effective Tax Rate -0.25%
Stock Price Statistics The stock price has increased by -47.26% in the
last 52 weeks. The beta is -1.99, so Structure Therapeutics's
price volatility has been lower than the market average.
Beta -1.99 52-Week Price Change -47.26% 50-Day Moving Average 19.82 200-Day Moving Average 25.29 Relative Strength Index (RSI) 25.17 Average Volume (20 Days) 811,356
Income Statement
Revenue n/a Gross Profit n/a Operating Income -158.23M Net Income -122.53M EBITDA -158.23M EBIT n/a Earnings Per Share (EPS) -2.33
Full Income Statement Balance Sheet The company has 169.51M in cash and 3.86M in
debt, giving a net cash position of 165.65M.
Cash & Cash Equivalents 169.51M Total Debt 3.86M Net Cash 165.65M Retained Earnings -329.1M Total Assets 816.44M Working Capital 760.26M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -116.64M
and capital expenditures -1.29M, giving a free cash flow of -117.93M.
Operating Cash Flow -116.64M Capital Expenditures -1.29M Free Cash Flow -117.93M FCF Per Share -2.24
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
